Healthcare Equipment and Supplies
Company Overview of Polymer Technology Systems, Inc.
Polymer Technology Systems, Inc. designs, develops, manufactures, and distributes point-of-care and home diagnostic testing tools for the healthcare industry. The company offers CardioChek PA, a point-of-care instrument that assists healthcare professionals in the differential diagnosis of lipid disorders; check strips, liquid controls, hand-held cholesterol analyzers, and accessories; and a range of single and combination tests for lipids, glucose, and ketone. It also provides Health Risk Assessment Software, a solution for corporate wellness markets and public screening environments to capture biometric data transferred directly from a CardioChek PA device linked to a computer. The company...
7736 Zionsville Road
Indianapolis, IN 46268
Founded in 1992
Key Executives for Polymer Technology Systems, Inc.
Chief Executive Officer, President and Director
Senior Vice President of International Sales and President of Asia Pacific
Chief Science & Technology Officer
Compensation as of Fiscal Year 2015.
Polymer Technology Systems, Inc. Key Developments
PTS Diagnostics Launches PTS Detect Cotinine System
Jul 28 15
PTS Diagnostics announced that the company has launched a new product line of handheld medical devices that provide rapid point-of-care test results previously only available from a venous draw sent to a laboratory. PTS Detect™ systems will allow healthcare professionals to further expand the number of fingerstick tests with results provided at the point of care. The first product in this new family innovates tobacco-use detection. The PTS Detect cotinine system is the only point-of-care device offering quantitative results from a fingerstick. The PTS Detect cotinine system is a portable device offering specific, reliable, accurate and fast results. The PTS Detect system measures quantified cotinine (a byproduct of nicotine) levels from 25 ng/ml to 200 ng/ml in just 5 minutes. In recent evaluations, the portable PTS Detect system provided results with similar sensitivity and specificity ranges as laboratory instruments. Another benefit is the cost savings that can be realized with the PTS Detect cotinine system. As a fingerstick test, the expense of employing phlebotomists is eliminated. With no shipping of specimens to the laboratory and fewer confirmatory tests, the PTS Detect cotinine system is well-positioned for the workplace. Further, the fingerstick collection can be done in conjunction with other onsite screenings.
PTS Diagnostics Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 03:00 PM
Jan 6 15
PTS Diagnostics Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 03:00 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Robert Huffstodt, CEO.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries